Abstract
Fetal and neonatal haemolytic disease, caused by red cell alloimmunisation, continues to occur despite well‐organised prophylaxis programmes. In the average obstetric practice pregnancies complicated by the presence of red cell alloantibodies are now a rarity. Increasingly, these patients are referred to the few specialised fetal medicine units where a team of obstetricians, neonatologists, haematologists, laboratory technicians and transfusion specialists take care of the management in close collaboration. In all these fields advances were made in the last decade, further improving the care of women with this potentially serious condition. In this review current insights and new developments are summarised.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
